WEARING-OFF FLUCTUATIONS IN PARKINSONS-DISEASE - CONTRIBUTION OF POSTSYNAPTIC MECHANISMS

被引:166
作者
BRAVI, D [1 ]
MOURADIAN, MM [1 ]
ROBERTS, JW [1 ]
DAVIS, TL [1 ]
SOHN, YH [1 ]
CHASE, TN [1 ]
机构
[1] NINCDS,EXPTL THERAPEUT BRANCH,BETHESDA,MD 20892
关键词
D O I
10.1002/ana.410360108
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Wearing-off phenomenon that complicates levodopa therapy of Parkinson's disease has been attributed to a reduction in striatal dopamine storage due to the progressive degeneration of presynaptic dopaminergic terminals. To determine whether postsynaptic mechanisms also contribute to these response fluctuations, the duration of the antiparkinsonian response in parkinsonian patients grouped by disease severity was compared following discontinuation of a steady-state optimal-dose infusion of apomorphine. Although the plasma half-life of this dopamine receptor agonist remained constant, its mean efficacy half-time declined from 66 minutes in early, levodopa-naive patients to 33 minutes in advanced, complicated parkinsonians (p < 0.005). Since the motor effects of apomorphine do not depend on the presence of dopaminergic terminals, changes at the postsynaptic level undoubtedly contribute to the diminished response duration. The only slightly greater attenuation of levodopa's motor effects observed previously under similar conditions suggests these postjunctional alterations, possibly involving relatively plastic striatal dopaminoceptive systems, account for most of the shortening in the duration of levodopa action that underlie wearing-off fluctuations.
引用
收藏
页码:27 / 31
页数:5
相关论文
共 17 条
  • [1] [Anonymous], 1982, MOVEMENT DISORD
  • [2] CONTINUOUS LISURIDE EFFECTS ON CENTRAL DOPAMINERGIC MECHANISMS IN PARKINSONS-DISEASE
    BARONTI, F
    MOURADIAN, MM
    DAVIS, TL
    GIUFFRA, M
    BRUGHITTA, G
    CONANT, KE
    CHASE, TN
    [J]. ANNALS OF NEUROLOGY, 1992, 32 (06) : 776 - 781
  • [3] BOLDRY RC, 1993, J PHARMACOL EXP THER, V267, P1454
  • [4] ACUTE EFFECTS OF PULSATILE LEVODOPA ADMINISTRATION ON CENTRAL DOPAMINE PHARMACODYNAMICS
    DAVIS, TL
    BRUGHITTA, G
    BARONTI, F
    MOURADIAN, MM
    [J]. NEUROLOGY, 1991, 41 (05) : 630 - 633
  • [5] Di Chiara G, 1978, Adv Pharmacol Chemother, V15, P87, DOI 10.1016/S1054-3589(08)60482-2
  • [6] DOPAMINERGIC MODULATION OF STRIATAL NEUROPEPTIDES - DIFFERENTIAL-EFFECTS OF D(1) AND D(2) RECEPTOR STIMULATION ON SOMATOSTATIN, NEUROPEPTIDE-Y, NEUROTENSIN, DYNORPHIN AND ENKEPHALIN
    ENGBER, TM
    BOLDRY, RC
    KUO, S
    CHASE, TN
    [J]. BRAIN RESEARCH, 1992, 581 (02) : 261 - 268
  • [7] LEVODOPA REPLACEMENT THERAPY ALTERS ENZYME-ACTIVITIES IN STRIATUM AND NEUROPEPTIDE CONTENT IN STRIATAL OUTPUT REGIONS OF 6-HYDROXYDOPAMINE LESIONED RATS
    ENGBER, TM
    SUSEL, Z
    KUO, S
    GERFEN, CR
    CHASE, TN
    [J]. BRAIN RESEARCH, 1991, 552 (01) : 113 - 118
  • [8] LEVODOPA PHARMACOKINETIC MECHANISMS AND MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE
    FABBRINI, G
    JUNCOS, J
    MOURADIAN, MM
    SERRATI, C
    CHASE, TN
    [J]. ANNALS OF NEUROLOGY, 1987, 21 (04) : 370 - 376
  • [9] MOTOR FLUCTUATIONS IN PARKINSONS-DISEASE - CENTRAL PATHOPHYSIOLOGICAL MECHANISMS .1.
    FABBRINI, G
    MOURADIAN, MM
    JUNCOS, JL
    SCHLEGEL, J
    MOHR, E
    CHASE, TN
    [J]. ANNALS OF NEUROLOGY, 1988, 24 (03) : 366 - 371
  • [10] PERIPHERAL PHARMACOKINETICS OF APOMORPHINE IN HUMANS
    GANCHER, ST
    WOODWARD, WR
    BOUCHER, B
    NUTT, JG
    [J]. ANNALS OF NEUROLOGY, 1989, 26 (02) : 232 - 238